Modulim
Modulim is dedicated to preserving tissue health by empowering clinicians with actionable microvascular and data insights for the lower limb. Their innovative technology solutions aim to reduce complications related to diabetes, kidney disease, and peripheral arterial disease, ultimately improving patient outcomes and satisfaction.
Modulim
2400 Barranca Parkway, Suite 2B Irvine, CA 92606
What We Do
The first non-contact, noninvasive microvascular assessment tool that uses spatial frequency domain imaging (SFDI) to measure tissue oxygenation and perfusion at the point-of-care in seconds.
A Limb Assessment, Management, & Preservation solution that integrates into existing workflows, allowing for efficient patient assessment and management.
A HIPAA compliant cloud infrastructure for secure storage and sharing of patient data, enabling better care coordination.
Spatial frequency domain imaging (SFDI) technology that provides noninvasive, quantitative measurements of tissue oxygen availability, extraction, and saturation.
Application Area
Battlefield Resuscitation
Regenerative Medicine
Key People
News & Updates
Modulim received a three-year renewal of their ISO:13485 certification after a comprehensive review of the company’s quality system.
Modulim announced the grant of United States Patent US11751769B2 for systems and methods to assess diabetic circulatory complications.
A new clinical case study was published assessing the impact of revascularization on microvascular oxygenation and perfusion using SFDI.
Patent granted for a system and method to assess diabetic circulatory complications.